Hot Keywords
Biomarker Discovery Autophagy and Cancer Breast Cancer Metastasis Brain Metastases Gastric Cancer Metastasis Lung Cancer Genetic Heterogeneity Colorectal Cancer Prostate Cancer Cancer Immunotherapy Circulating Tumor Cells Neuroendocrine Tumors

Top
Topic: Melanoma Brain Metastasis

A special issue of Journal of Cancer Metastasis and Treatment

ISSN 2454-2857 (Online), ISSN 2394-4722 (Print)

Submission deadline: 30 Jun 2021

Guest Editor(s)

  • Prof. Dario Marchetti
    Division of Molecular Medicine, Department of Internal Medicine, The University of New Mexico Health Sciences Center, Albuquerque, NM, USA.  

    Website | E-mail

Special Issue Introduction

Dear Colleagues,

Brain metastasis represents a significant clinical and biological challenge with highly devastating and lethal consequences. An estimated 20% of all cancer patients will develop brain metastasis; however, this estimate is likely defective since autopsy studies have suggested a higher incidence (approximately 40%) of intracranial metastasis in patients with cancer. This special issue focuses on melanoma brain metastasis (MBM) which is diagnosed clinically in up to 60% of metastatic melanoma patients, and in up to 80% of patients at autopsy, and is a frequent initial site of disease progression. Notably, the overall patient survival of 2-5 years remains dismal at 8.1% and 2.4%, respectively, with a median overall survival of only 4 months from diagnosis. To date, MBM therapies include neurological resection of MBM lesions, stereotactic radiosurgery, whole brain radiotherapy for widespread disease, targeted therapy, and immunotherapy. While the latter has shown some significant activity, it is often less than what is observed for patients with only extracranial metastases. Furthermore, standard treatments result in high neurotoxicity, exacerbated by the fact that chemotherapeutic approaches are difficult to achieve dose success in the brain/central nervous system (CNS) due to the presence of the blood-brain barrier (BBB).

The objective of this special issue is to publish the latest advances in MBM basic and translational research, and clinical implementation combating MBM. Contributions outlining discoveries in MBM biological and clinical settings, including biological, technical, pre-clinical models, and clinical advances are welcome.

Submission Deadline

30 Jun 2021

Submission Information

Articles of special issue are free of charge for article processing.
For Author Instructions, please refer to http://jcmtjournal.com/pages/view/author_instructions
For Online Submission, please login at https://oaemesas.com/JCMT/?IssueId=567
Submission Deadline: 30 Jun 2021
Contacts: Olivia Zhao, Assistant Editor, olivia@jcmtjournal.com

Published Articles

This special issue is now open for submission.
Copyright © 2021 OAE Publishing Inc. All Rights Reserved.